malaria vaccine RTS
Selected indexed studies
- RTS,S/AS01 malaria vaccine-proven safe and effective? (Lancet Infect Dis, 2023) [PMID:37086747]
- RTS,S: the first malaria vaccine. (J Clin Invest, 2022) [PMID:34981788]
- The RTS,S malaria vaccine: Current impact and foundation for the future. (Sci Transl Med, 2022) [PMID:36383682]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- RTS,S/AS01 malaria vaccine-proven safe and effective? (2023) pubmed
- RTS,S: the first malaria vaccine. (2022) pubmed
- The RTS,S malaria vaccine: Current impact and foundation for the future. (2022) pubmed
- The RTS,S malaria vaccine. (2010) pubmed
- Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. (2015) pubmed
- Malaria: Biology and Disease. (2016) pubmed
- First Malaria Vaccine RTS, S: A Step toward the Eradication of Malaria. (2024) pubmed
- The RTS,S vaccine candidate for malaria. (2011) pubmed
- Malaria Vaccines: Progress to Date. (2023) pubmed
- RTS,S/AS01E malaria vaccine (MoSQUIRIX*) Children living in malaria-endemic regions: little efficacy, poorly documented harms. (2017) pubmed